Next Article in Journal
Aptamer Therapeutics in Cancer: Current and Future
Previous Article in Journal
New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response
Previous Article in Special Issue
The Epithelial-to-Mesenchymal Transition in Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52

Laboratoire EBI, SEVE, UMR-CNRS 7267, Université de Poitiers, F-86073 Poitiers, France
Cancers 2018, 10(3), 79; https://doi.org/10.3390/cancers10030079
Submission received: 12 March 2018 / Revised: 12 March 2018 / Accepted: 13 March 2018 / Published: 19 March 2018
(This article belongs to the Special Issue The Epithelial-to-Mesenchymal Transition (EMT) in Cancer)
The author wishes to make the following correction to the paper [1]. The following paragraph and the corresponding reference were added [2] (as reference 16 in the Editorial):
“Next, Duchemin-Pelletier et al. present data about the role of CK2β, the regulatory subunit of the ubiquitous protein kinase CK2 [16]. In MCF10A mammary epithelial cells where CK2β expression was downregulated, the authors provide evidence that CK2β downregulation can promote the acquisition of characteristics commonly associated with the cancer stem cell phenotype. They demonstrate that a CK2β level establishes a critical cell fate threshold in the control of epithelial cell plasticity. Since EMT supports the induction stem-cell phenotype, identifying the CK2 substrates will improve the discovery of new specific markers for breast cell stemness.”
The reference numbering was also corrected.
The author would like to apologize for any inconvenience caused. The manuscript will be updated and the original will remain online on the article webpage.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers 2018, 10, 52. [Google Scholar] [CrossRef] [PubMed]
  2. Duchemin-Pelletier, E.; Baulard, M.; Spreux, E.; Prioux, M.; Burute, M.; Mograbi, B.; Guyon, L.; Théry, M.; Cochet, C.; Filhol, O. Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells. Cancers 2017, 9. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Roche, J. Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers 2018, 10, 79. https://doi.org/10.3390/cancers10030079

AMA Style

Roche J. Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers. 2018; 10(3):79. https://doi.org/10.3390/cancers10030079

Chicago/Turabian Style

Roche, Joëlle. 2018. "Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52" Cancers 10, no. 3: 79. https://doi.org/10.3390/cancers10030079

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop